Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lifecare ASAFRA:LFC0 -7.41%13 Equity-to-Asset is 0.87 as of Jun. 2026, which is 16% above its 10-year median of 0.75. GuruFocus rates FRA:LFC0 with a GF Score™ of 13/100 and a GF Value™ of €0.24 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Lifecare ASA ranks better than 89.2% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Lifecare ASA's Total Stockholders Equity for the quarter that ended in Jun. 2026 was €4.90 Mil. Lifecare ASA's Total Assets for the quarter that ended in Jun. 2026 was €5.56 Mil.
Therefore, Lifecare ASA's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.87.
The historical rank and industry rank for Lifecare ASA's Equity-to-Asset or its related term are showing as below:
FRA:LFC0'
s Equity-to-Asset Range Over the Past 10 Years
Min: -1.98 Med: 0.75 Max: 0.99
Current: 0.88
During the past 10 years, the highest Equity to Asset Ratio of Lifecare ASA was 0.99. The lowest was -1.98. And the median was 0.75.
FRA:LFC0's Equity-to-Asset is ranked better than 89.2% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs FRA:LFC0: 0.88
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Lifecare ASA Equity-to-Asset Related Terms
Lifecare ASA Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Lifecare ASA's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:LFC0 vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, Lifecare ASA's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifecare ASA Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifecare ASA's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Lifecare ASA's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Lifecare ASA's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lifecare ASA (FRA:LFC0) has a Equity-to-Asset of 0.87 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Lifecare ASA and its competitors. This is 16% above median its historical median of 0.75. According to the industry distribution chart, Lifecare ASA ranks #92 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 10.8%.
Is Lifecare ASA's Equity-to-Asset too high?
Lifecare ASA's current Equity-to-Asset of 0.87 is 16% above median its 10-year median of 0.75. The Medical Devices & Instruments industry median Equity-to-Asset is 0.64. Lifecare ASA's value of 0.87 is 35.9% above this industry median. Based on the distribution chart, Lifecare ASA ranks #92 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lifecare ASA has a GF Score™ of 13/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifecare ASA's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Lifecare ASA ranks #92 out of 852 companies for Equity-to-Asset. This places Lifecare ASA in the top 11% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.64. Lifecare ASA's value of 0.87 is 35.9% above this benchmark. While the company's 10-year median is 0.75 vs. the industry median of 0.64, Lifecare ASA has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lifecare ASA's current Equity-to-Asset of 0.87 is 35.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Lifecare ASA and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifecare ASA's current Equity-to-Asset is 0.87, which is 16% above median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifecare ASA stock overvalued right now?
Based on GuruFocus' analysis, Lifecare ASA (FRA:LFC0) is currently considered Possible Value Trap. The stock's GF Value™ is €0.24, compared to a current price of €0.02 — trading 91.7% below its estimated fair value. The current Equity-to-Asset is 0.87, which is 16% above median its 10-year median of 0.75 and 35.9% above the Medical Devices & Instruments industry median of 0.64. Lifecare ASA's overall GF Score™ is 13/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Lifecare ASA (FRA:LFC0), the current Equity-to-Asset is 0.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifecare ASA (FRA:LFC0) Overvalued in 2026?
Based on GuruFocus' analysis, Lifecare ASA stock appears to be undervalued.
The current stock price of €0.02 is trading 91.7% below its estimated GF Value™ of €0.24.
GuruFocus considers Lifecare ASA to be Possible Value Trap.
Key valuation signals for FRA:LFC0:
Equity-to-Asset: 0.87 (16% above median its 10-year median of 0.75)
GF Value™: €0.24 vs. price of €0.02 (91.7% below fair value)
Industry Position: 35.9% above the Medical Devices & Instruments median (#92 of 852)
No single metric tells the full story. See the FRA:LFC0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. It is focused on advancing continuous glucose monitoring systems and uses osmotic pressure as a sensing method. Its technology can be applied to detect and monitor various analytes and molecules in humans and animals. The company operates as a single segment focused on research and development (R&D) of its osmotic pressure sensor and related components.
13GF Score
Get the complete analysis for FRA:LFC0
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LFC0 has been successfully added to your 
